Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.11
+0.63 (7.77%)
Jun 17, 2025, 4:00 PM - Market closed
Nuvectis Pharma Employees
Nuvectis Pharma had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,550,846
Market Cap
191.68M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | 2 | 18.18% |
| Dec 31, 2022 | 11 | 3 | 37.50% |
| Dec 31, 2021 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NVCT News
- 4 weeks ago - Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - GlobeNewsWire
- 6 weeks ago - Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting - GlobeNewsWire
- 3 months ago - Nuvectis Pharma to Participate in the 37th Annual Roth Conference - GlobeNewsWire
- 4 months ago - Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter's Over-Allotment Option - GlobeNewsWire
- 4 months ago - Nuvectis: Additional Data In Q2 Of 2025 Could Allow It To Stage A Comeback - Seeking Alpha
- 4 months ago - Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock - GlobeNewsWire
- 4 months ago - Nuvectis Pharma Announces Proposed Public Offering of Common Stock - GlobeNewsWire